“Over the past two decades, Dr Gustaf Tegler has built Uppsala University Hospital’s successful service for complex venous disease. The programme brings together vascular surgeons, interventional radiologists, and thrombosis specialists to manage acute iliofemoral and iliocaval deep vein thrombosis (DVT), post-thrombotic syndrome (PTS), non-thrombotic iliac vein lesions (NIVL) and pelvic venous disorders.
This service builds on a long tradition; Dr Ingvar Eriksson developed an extensive practice in open venous reconstruction, including valve repair and transposition, while Professor David Bergqvist made important contributions to venous thromboembolism research.
Dr Tegler has also chaired the Scandinavian Venous Forum since 2022. With roots dating back to 1963, the organisation brings together colleagues from the five Nordic countries and holds annual scientific meetings.”
Why EVeR matters to us
“The European Venous Registry (EVeR) can help improve patient selection by capturing both invasive and conservative treatment of acute DVT, PTS and NIVL, and comparing outcomes across treatment strategies.
The key question is: Did the patient actually get better? Patients seek symptom relief and improved quality of life. Stent patency matters, but a patent stent without clinical improvement is insufficient.
Combining anatomical and procedural data with validated clinical scores and patient-reported outcomes across centres and countries can help us select the right treatment for the right venous patient.”